CSIMarket Company Name, Ticker, Suppliers, else..


Abbott Laboratories  (ABT)
Other Ticker:  
 

Abbott Laboratories

ABT's Fundamental analysis



Abbott Laboratories's sales fell by -18.06 % in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 948

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.24 %

Abbott Laboratories's net profit deacreased by -46.14 % in I. Quarter 2023 year on year, to $1,318 millions.

• More on ABT's Growth


Abbott Laboratories
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 121.26 in trailing twelve-month period.
Company
31.24
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 4.34.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.05.


• More on ABT's Valuation
 
 Total Debt (Millions $) 16,900
 Dividend TTM ($) 1.91 $
 Dividend Yield TTM (%) 1.97 %
 Revenue/Employee (TTM) $ 367,301
 Net Income/Employee (TTM) $ 51,363
 Receivable Turnover (TTM) 6.42
 Tangible Book Value (Per Share $) 2.45

Abbott Laboratories
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 121.26 in trailing twelve-month period.
Company
31.24
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 4.34.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.05.

Abbott Laboratories Price to Book Ratio is at 4.84 higher than Indusry Avg. of -1004.47, and lower than S&P 500 Avg. of 1255.17

• More on ABT's Valuation

•  Market Capitalization (Millions $) 180,199
•  Shares Outstanding (Millions) 1,752
•  Employees 113,000
•  Revenues (TTM) (Millions $) 41,505
•  Net Income (TTM) (Millions $) 5,804
•  Cash Flow (TTM) (Millions $) 1,486
•  Capital Exp. (TTM) (Millions $) -1,836
•  Total Debt (Millions $) 16,900
•  Dividend TTM ($) 1.91 $
•  Dividend Yield TTM (%) 1.97 %
•  Revenue/Employee (TTM) $ 367,301
•  Net Income/Employee(TTM) $ 51,363
•  Receivable Turnover Ratio (TTM) 6.42
•  Tangible Book Value (Per Share $) 2.45

•  Market Capitalization (Millions $) 180,199
•  Shares Outstanding (Millions) 1,752
•  Employees 113,000
•  Revenues (TTM) (Millions $) 41,505
•  Net Income (TTM) (Millions $) 5,804
•  Cash Flow (TTM) (Millions $) 1,486
•  Capital Exp. (TTM) (Millions $) -1,836


    ABT's Profitability Comparisons
Abbott Laboratories achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2023 to 15.48 % from 12.92 % in IV. Quarter.

Abbott Laboratories net profit margin of 13.52 % is currently ranking no. 25 in Major Pharmaceutical Preparations industry, ranking no. 63 in Healthcare sector and number 999 in S&P 500.


Profitability by Segment
Established Pharmaceutical Products 18.42 %
Nutritionals 25.66 %
Vascular 35.57 %
Diagnostics 26.56 %



  Ratio
•   Capital Ratio (MRQ) 1.68
•  Total Debt to Equity (MRQ) 0.45
•  Tangible Leverage Ratio (MRQ) 6.83
•  Asset Turnover Ratio (TTM) 0.56
•  Inventory Turnover Ratio (TTM) 3.02



Abbott Laboratories achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2023 to 15.48 % from 12.92 % in IV. Quarter.

Abbott Laboratories net profit margin of 13.52 % is currently ranking no. 25 in Major Pharmaceutical Preparations industry, ranking no. 63 in Healthcare sector and number 999 in S&P 500.

• More on ABT's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071